Across all six studies, the safety findings were consistent: no serious adverse events, no immunogenic responses, no changes in IGF-1, no glucose or insulin disruption
Long-term human safety data is absent
Contact us via Telegram for shipping estimates and tracking
Not intended for human or animal use, ingestion, or injection
The drug was diluted to a concentration of 50 mM in DMSO
Vet Immunol Immunopathol 139:308312 Conejeros I, Jara E, Carretta MD, Alarcn P, Hidalgo MA, Burgos RA (2012) 2-Aminoethoxydiphenyl borate (2-APB) reduces respiratory burst, MMP-9 release and CD11b expression, and increases l-selectin shedding in bovine neutrophils